Lecture 14 - Antifungals Flashcards
Eukaryotic - ______
mycoses
Cell membrane contains _______
ergosterol
Cell wall; ____ is a polymer of N-acetylglucosamine
chitin
Describe how Amphotericin B is used in “Subcutaneous and systemic mycotic infections”
- Polyene macrolide
- Produced by Streptomyces nodosus
- For life threatening disease
- Binds to ergosterol - not cholesterol
- Forms pores
- Wide range of fungi
- Candida and blastomyces
- Used against aspergillum and protozoa (leishmaniasis)
- 1st line therapy and then substituted
Describe the pharmacokinetics of Amphotericin B
- poorly absorbed from GI tract, intravenous
- insoluble in water
- intrathecal for meningitis
- delivered in liposomes - lower toxicity
Adverse effects of Amphotericin B
- low therapeutic index
- daily dose < 1.5 mg/kg
Effects that may happen after the initial infusion of amphotericin B?
- anaphylaxis and convulsions
- fever
- hypotension
Effects that may happen after a longer term treatment of Amphotericin B?
- renal impairment
- anemia
- neurological effects
- thrombophlebitis (blood clot formation)
Describe Flucytosine (5-FC)
- synthetic pyrimidine antimetabolite
- enters via specific cytosine permeate - not in mammals
- converted to 5’-fluorodeoxyuridine monophosphate (5-FdUMP)
- false nucleotide inhibits thymidylate synthase
- blocks thymidylic acid - needed for DNA
- synergy with amphotericin B
- limited spectrum (candida and some molds)
Resistance to Flucytosine
Target enzyme can be down-regulated and lead to resistance - need for combination therapy
Pharmacokinetics of Flucytosine
- water soluble
- good BBB passage
Adverse effects of flucytosine ?
- neutropenia (low neutrophil number)
- bone marrow depression
- nausea, vomiting
- contraindicated with renal impairment
Toxic metabolite of flucytosine?
fluorouracil
Describe posaconazole
- synthetic triazole for systemic fungi infection
- inhibits C-14 alpha demethylase (cyt P450 enzyme)
- blocks demethylation of lanosterol to ergosterol
- disrupts membrane structure/function
- oral with high absorption
- more specific than previous azoles (itraconazole) and imidazole (ketoconazole)
- wide fungi range - species of Candida and Aspergillus
- Resistance becoming a problem in HIV patients
Pharmacokinetics of Posaconazole
- oral: gastric acid needed
- major binding to plasma proteins
- metabolized by liver
- poor CNS penetration
Adverse effects of Posaconazole
minor GI upset
Drug interactions with Posaconazole
Inhibition of Cyt P450 (rifampin an inducer)
Describe Caspofungin
- new group of fungicides
- echinocandins
- inhibit B-1,3-D-glycan
- cell wall disruption and death
- Aspergillus and candida
- T1/2 of 9-11 hour
- 2nd line therapy
Drugs for cutaneous mycotic infections (dermatophytes - ringworm)
Terbinafine:
- Inhibit squalene epoxidase and blocks ergosterol
- Squalene build-up is toxic
- 3 month therapy
- Oral; 40% bioavailability
- Accumulates in breast milk
- Gastrointestinal disturbance
Problem with treating eukaryotes with antiprotozoal drugs?
metabolism close to humans